Study guide
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism
UEMS European Board of Dermatovenereology Diploma Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Eligibility & Examination Regulations
1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition
2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology
2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns
3 Chapter 3: Dermatopathology & Diagnostic Procedures
3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy
4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology
4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance
5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease
5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders
6 Chapter 6: Hair, Nails & Pigmentary Disorders
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation
7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease
7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses
8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease
8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease
9 Chapter 9: Autoimmune Bullous Diseases
9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis
10 Chapter 10: Eczematous Disorders, Urticaria & Allergology
10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy
11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis
11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses
12 Chapter 12: Paediatric & Genetic Dermatology
12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa
13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections
13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
14 Chapter 14: Viral & Fungal Cutaneous Infections
14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses
15 Chapter 15: Sexually Transmitted Infections & Genital Infections
15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis
16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine
16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems
17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours
17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases
18 Chapter 18: Melanocytic Naevi & Melanoma
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma
19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas
19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas
20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing
20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy
21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy
22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision
22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism
Key Takeaways Explain This Topic AI
About 85% to 90% of scalp hairs are in anagen, which lasts about 2 to 7 years, while telogen lasts about 3 months and normal shedding is up to about 100 hairs a day.
Telogen effluvium usually begins 2 to 3 months after a trigger such as fever, childbirth, surgery, crash dieting, or a new drug, and a pull test yields club (telogen) hairs.
Baricitinib is approved in the EU for severe alopecia areata in adults, and ritlecitinib is approved for severe alopecia areata from 12 years of age.
Frontal fibrosing alopecia is a lymphocytic scarring alopecia, mainly of postmenopausal women, causing frontotemporal hairline recession, eyebrow loss, and perifollicular erythema.
In tinea capitis, Trichophyton infection responds best to oral terbinafine, whereas Microsporum canis responds better to griseofulvin and shows green fluorescence under Wood light.
Last updated: September 2026
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism
The first question in any hair consultation is: are the follicular openings preserved? Non-scarring alopecia keeps the openings and is potentially reversible. Scarring alopecia destroys them and is permanent, so it needs early diagnosis and treatment.
The Hair Cycle
- Phase Duration (scalp) Proportion of Hairs Notes
- Anagen (growth) About 2–7 years 85–90% Length of anagen sets maximum hair length
- Catagen (regression) About 2–3 weeks About 1% Apoptosis of the lower follicle
- Telogen (resting) About 3 months 10–15% Ends with shedding of a club hair
- Exogen / kenogen Variable — Active shedding; empty follicle before new anagen
A normal scalp has about 100,000 hairs and sheds up to about 100 a day.
Diagnostic tools: the pull test (gently pulling about 60 hairs; more than about 6 extracted suggests active shedding), trichoscopy (dermoscopy of the scalp), trichogram, and biopsy (4 mm punch, with horizontal and vertical sections) for scarring alopecia.
- Non-Scarring Alopecia
- Androgenetic Alopecia (AGA)
Mechanism: dihydrotestosterone-driven follicular miniaturisation in genetically predisposed follicles, with shortening of anagen.
Male pattern: frontotemporal recession and vertex thinning (Hamilton-Norwood scale).
Female pattern: diffuse thinning over the crown with a preserved frontal hairline and a widened central part (Ludwig or Sinclair scales). Look for hyperandrogenism (acne, hirsutism, irregular periods).
Trichoscopy: hair diameter variation of more than 20%, yellow dots, and perifollicular pigmentation.
Treatment: topical minoxidil (5% for men; 2% or 5% for women); oral finasteride 1 mg for men (the EU label lists mood changes, including suicidal ideation, and sexual side effects); low-dose oral minoxidil and dutasteride (off-label); spironolactone or other antiandrogens in women; platelet-rich plasma; and hair transplantation.
Telogen Effluvium
Diffuse shedding 2–3 months after a trigger : high fever, childbirth, surgery, crash dieting, severe illness, iron deficiency, thyroid disease, or drugs (retinoids, anticoagulants, beta-blockers, antithyroid drugs).
The pull test is positive with club (telogen) hairs .
Check ferritin, thyroid function, and other causes suggested by the history. Acute telogen effluvium recovers within about 6 months once the trigger is removed. Chronic telogen effluvium lasts over 6 months, typically in middle-aged women.
Anagen Effluvium
Abrupt loss of growing hairs within days to weeks of chemotherapy (especially taxanes and anthracyclines), radiotherapy, or poisoning (thallium). Scalp cooling reduces chemotherapy-related loss. Regrowth is usual, except for permanent alopecia after some regimens such as high-dose busulfan or docetaxel.
Alopecia Areata (AA)
Autoimmune: T-cell attack on the anagen hair bulb after loss of immune privilege, driven by interferon-gamma and IL-15 through JAK signalling.
Clinical: round smooth patches, alopecia totalis (whole scalp), alopecia universalis (whole body), and ophiasis (band along the occipital and temporal margin, with a poor prognosis). Nail pitting and trachyonychia are common.
Trichoscopy: exclamation-mark hairs , yellow dots, black dots, broken and tapered hairs.
Associations: atopy, autoimmune thyroid disease, vitiligo, and Down syndrome.
Severity: the SALT score (Severity of Alopecia Tool) gives the percentage of scalp hair loss. SALT ≥ 50 is severe.
Treatment: intralesional triamcinolone for limited patches; potent topical corticosteroids; contact immunotherapy (diphenylcyclopropenone); systemic corticosteroid pulses; and the oral JAK inhibitors baricitinib (EU-approved for severe AA in adults) and ritlecitinib (EU-approved for severe AA from 12 years). Relapse is common after stopping.
Tinea Capitis
Most common in children. Organisms: endothrix Trichophyton tonsurans (common in urban Europe) and T. violaceum ; ectothrix Microsporum canis (from cats and dogs, green fluorescence under Wood light).
Patterns: scaly patches, "black dot" broken hairs, diffuse scale like seborrhoeic dermatitis, pustules, and kerion (a boggy inflammatory mass that can scar).
Treatment must be oral: Trichophyton responds best to terbinafine ; Microsporum responds better to griseofulvin (not available in all European countries) or itraconazole. Use antifungal shampoo to reduce spread, and screen family members.
Trichotillomania
Compulsive hair pulling produces bizarre patches with broken hairs of different lengths . Trichoscopy shows flame hairs, V-sign, coiled hairs, and hair powder . Management is behavioural (habit-reversal training), with N-acetylcysteine as an option. This is covered further in the psychodermatology section.
Primary Scarring (Cicatricial) Alopecia
Group Disorders Features and Treatment
Lymphocytic Discoid lupus erythematosus; lichen planopilaris ; frontal fibrosing alopecia (FFA) ; central centrifugal cicatricial alopecia; pseudopelade of Brocq LPP: perifollicular erythema and scale. FFA: frontotemporal recession, eyebrow loss , facial papules, "lonely hairs", mostly postmenopausal women. Treatment: potent and intralesional steroids, hydroxychloroquine, 5-alpha-reductase inhibitors (FFA), doxycycline
Neutrophilic Folliculitis decalvans ; dissecting cellulitis Folliculitis decalvans: pustules and tufted hairs , linked to Staphylococcus aureus ; treat with clindamycin + rifampicin or doxycycline. Dissecting cellulitis: boggy nodules and tunnels, part of the follicular occlusion tetrad; isotretinoin, TNF inhibitors
Mixed Acne keloidalis nuchae; folliculitis (acne) necrotica Acne keloidalis: papules and keloidal plaques on the occiput of men with curly hair
Hair Shaft Abnormalities
- Defect Appearance Association
- Monilethrix Beaded hair with fragile constrictions Keratin gene mutations ( KRT81 , KRT83 , KRT86 )
- Pili torti Hair twisted 180° on its axis Menkes disease ( ATP7A , copper transport) and other syndromes
Trichorrhexis invaginata ("bamboo hair") Distal shaft telescoped into proximal shaft Netherton syndrome ( SPINK5 )
Trichorrhexis nodosa Frayed nodes like two brushes pushed together Weathering, arginosuccinic aciduria
Trichothiodystrophy "Tiger-tail" banding under polarised light Low sulphur content; some forms have photosensitivity
Uncombable hair syndrome Spun-glass hair that cannot be combed flat; triangular shaft Usually improves in childhood
Hirsutism and Hypertrichosis
Hirsutism: male-pattern terminal hair growth in women, scored by the modified Ferriman-Gallwey scale (cut-offs vary by ethnicity, often about 8). The most common cause is polycystic ovary syndrome . Rapid onset with virilisation suggests an androgen-secreting tumour. Treatment: combined oral contraceptives, antiandrogens, topical eflornithine, and laser hair removal.
Hypertrichosis: excess hair in a non-androgen pattern, either congenital or acquired (drugs such as ciclosporin, minoxidil, and phenytoin; porphyria cutanea tarda; anorexia nervosa). Acquired hypertrichosis lanuginosa can signal internal malignancy.